Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu(a t-PA/u-PA Chimera) in a combined arterial and venous thrombosis model in the dog

This publication has 18 references indexed in Scilit:

• Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
  Circulation, 1991
• In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator.
  Circulation Research, 1990
• A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysis
  Journal of the American College of Cardiology, 1989
• Innovative Approaches to Plasminogen Activator Therapy
  Science, 1989
• Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.
  Circulation, 1988
• Thrombolytic Therapy
  Annual Review of Medicine, 1988
• Molecular mechanisms of fibrinolysis and their application to fibrin‐specific thrombolytic therapy
  Journal of Cellular Biochemistry, 1987
• Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin.
  Circulation, 1986
• Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.
  Heart, 1985
• Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
  Journal of Clinical Investigation, 1982